News Release
 

August 26, 2010

CONTACT: Jessica Mikulski
215-349-8369
jessica.mikulski@uphs.upenn.edu

Penn Medicine - University of Pennsylvania School of Medicine and University of Pennsylvania Health System


This release is available online at
http://www.uphs.upenn.edu/news/News_Releases/2010/08/anesthesia-sleep-wake-transition/

Penn Study Sheds Light on How the Brain Transitions Between Sleep and Awake States Under Anesthesia

 “Neural Inertia” May Explain the Brain’s Resistance to Changes in Consciousness


PHILADELPHIA – Despite the fact that an estimated 25 million patients per year in the U.S. undergo surgeries using general anesthesia, scientists have only been able to hypothesize exactly how anesthetics interact with the central nervous system. They previously thought that the processes of “going under” and waking up from anesthesia affected the brain in the same way. Now, researchers at the University of Pennsylvania School of Medicine have established in animal models that the brain comes in and out of a state of induced unconsciousness through different processes. The findings, published in PLoS One, may help researchers better understand serious sleep disorders and states of impaired consciousness such as comas. 

“One major unanswered question in neuroscience is how the brain transitions between conscious and unconscious states,” said senior author Max B. Kelz, MD, PhD, assistant professor of Anesthesiology and Critical Care. “Our results suggest that the brain keeps track of whether it is conscious or offline in an unconscious state. We are working to understand the mechanisms through which the brain accomplishes this feat.  Studying general anesthetics in animal models offers a controllable means to investigate this newly recognized behavioral barrier that separates conscious from unconscious states.”

Induction of anesthesia is commonly attributed to drug-induced modifications of neuronal function, whereas emergence from anesthesia has been thought to occur passively, with the elimination of the anesthetic from sites in the central nervous system (CNS). If this were true, then CNS anesthetic concentrations on induction and emergence would be indistinguishable.

However, by generating anesthetic dose response data in both fruit flies and mice, the researchers demonstrated that the forward and reverse paths through which anesthetic-induced unconsciousness arises and dissipates are not identical. Instead the animal subjects exhibited a delay in return to a state of consciousness despite the reduced concentration of the anesthetic.

The researchers observed that once a group of animal subjects underwent a transition from wakefulness to anesthetic-induced unconsciousness, the subjects exhibited resistance to the return of the wakeful state. Based on their findings, the authors propose a fundamental and biologically conserved state, which they call neural inertia, a tendency of the CNS to resist transitions between consciousness and unconsciousness.

“The findings from this study may provide insights into the regulation of sleep as well as states in which return of consciousness is pathologically impaired such as some types of coma,” said Kelz. “This line of research may one day help us to develop novel anesthetic drugs and targeted therapies for patients who have different forms of sleep disorders or who have the potential to awaken from coma but remain stuck in comatose states for months or years.”

The study was conducted by a collaborative team of researchers from several departments and centers at the University of Pennsylvania School of Medicine including: Eliot B. Friedman, Department of Medicine, Center for Sleep and Respiratory Neurobiology, and the Institute for Translational Medicine; Yi Sun, Department of Anesthesiology and Critical Care;  Jason T. Moore, Department of Anesthesiology and Critical Care  and the Mahoney Institute for Neurosciences;  Hsiao-Tung Hung, Department of Medicine and the Center for Sleep and Respiratory Neurobiology;  Qing Cheng Meng, Department of Anesthesiology and Critical Care; Priyan Perera, Department of Anesthesiology and Critical Care; Steven A. Thomas, Department of Pharmacology;  Roderic G. Eckenhoff, Department of Anesthesiology and Critical Care; and Amita Sehga, the Center for Sleep and Respiratory Neurobiology.

Editors' notes:
This work was funded in part by an American Recovery and Reinvestment Act grant.  Additional funding was provided by the National Institute for General Medical Sciences,  the Foundation for Anesthesia Education and Research, University of Pennsylvania’s Institute for Translational Medicine and Therapeutics, the Harold Amos Medical Faculty Development Program from the R.W. Johnson Foundation, the Parker B. Francis Fellowship program, and the University of Pennsylvania Department of Anesthesiology and Critical Care.

###

Penn Medicine is one of the world's leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $4.3 billion enterprise.

The Perelman School of Medicine has been ranked among the top five medical schools in the United States for the past 17 years, according to U.S. News & World Report's survey of research-oriented medical schools. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $392 million awarded in the 2013 fiscal year.

The University of Pennsylvania Health System's patient care facilities include: The Hospital of the University of Pennsylvania -- recognized as one of the nation's top "Honor Roll" hospitals by U.S. News & World Report; Penn Presbyterian Medical Center; Chester County Hospital; Penn Wissahickon Hospice; and Pennsylvania Hospital -- the nation's first hospital, founded in 1751. Additional affiliated inpatient care facilities and services throughout the Philadelphia region include Chestnut Hill Hospital and Good Shepherd Penn Partners, a partnership between Good Shepherd Rehabilitation Network and Penn Medicine.

Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2013, Penn Medicine provided $814 million to benefit our community.